Cite
MLA Citation
Manfred Westphal et al.. “A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma.” European journal of cancer, vol. 51, no. 4, n.d., pp. 522–532. http://access.bl.uk/ark:/81055/vdc_100156216656.0x000022